Inventor
SYLVIA RICHARD-BILDSTEIN
Inventor
CH
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
C07BGeneral methods of organic chemistry4%
PatentTitleYear
12,011,444N-substituted indole derivatives as PGE2 receptor modulators202411,839,613Pyrimidine derivatives as PGE2 receptor modulators202311,712,438Phenyl derivatives as PGE2 receptor modulators202311,446,298Pyrimidine derivatives202211,325,899Benzofurane and benzothiophene derivatives as PGE2 receptor modulators202211,306,078Piperidine CXCR7 receptor modulators202211,241,431N-substituted indole derivatives as PGE2 receptor modulators202211,136,317NADPH oxidase 4 inhibitors2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to ACTELION PHARMACEUTICALS LTD (1)· patent assignee history
2021–2024Based in CH· patent location history
2022–2024Patents assigned to IDORSIA PHARMACEUTICALS LTD (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IDORSIA PHARMACEUTICALS LTD | 7 | 2022–2024 |
| ACTELION PHARMACEUTICALS LTD | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| CH | 8 | 2021–2024 |